Based on the earlier data of Pim1 kinase protein structure and the importance of bis-thiazole potential cytotoxicity, this study aimed to design novel bis-thiazole derivatives as preferential Pim1 inhibitors to treat the underlying cancer types. Here, PIM1 is linked to cancer.